Hypertension in patients with diabetes: questions

UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)

GL Bakris, RD Toto, PA McCullough, R Rocha, D Purkayastha, P Davis, GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators, Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study Kidney International. ,vol. 73, pp. 1303- 1309 ,(2008) , 10.1038/KI.2008.102

Zachary T. Bloomgarden, Fredda Ginsberg-Fellner, Elliot J. Rayfield, John Bookman, W.Virgil Brown, Elevated hemoglobin A1c and low-density lipoprotein cholesterol levels in thiazide-treated diabetic patients The American Journal of Medicine. ,vol. 77, pp. 823- 827 ,(1984) , 10.1016/0002-9343(84)90518-7

V. Basevi, S. Di Mario, C. Morciano, F. Nonino, N. Magrini, Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61 Diabetes Care. ,vol. 34, ,(2011) , 10.2337/DC11-0174

George L. Bakris, Mark Williams, Lance Dworkin, William J. Elliott, Murray Epstein, Robert Toto, Katherine Tuttle, Janice Douglas, Willa Hsueh, James Sowers, Preserving renal function in adults with hypertension and diabetes: A consensus approach American Journal of Kidney Diseases. ,vol. 36, pp. 646- 661 ,(2000) , 10.1053/AJKD.2000.16225

Gordon T Mcinnes, `Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) The British Journal of Diabetes & Vascular Disease. ,vol. 3, pp. 263- 267 ,(2003) , 10.1177/14746514030030040501

Leonard Pogach, David Aron, Balancing hypoglycemia and glycemic control: a public health approach for insulin safety. JAMA. ,vol. 303, pp. 2076- 2077 ,(2010) , 10.1001/JAMA.2010.655

I. M. Stratton, C. A. Cull, A. I. Adler, D. R. Matthews, H. A. W. Neil, R. R. Holman, Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. ,vol. 49, pp. 1761- 1769 ,(2006) , 10.1007/S00125-006-0297-1

S. Zoungas, B. E. de Galan, T. Ninomiya, D. Grobbee, P. Hamet, S. Heller, S. MacMahon, M. Marre, B. Neal, A. Patel, M. Woodward, J. Chalmers, , Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes New results from the ADVANCE trial Diabetes Care. ,vol. 32, pp. 2068- 2074 ,(2009) , 10.2337/DC09-0959

Jan Östergren, Neil R Poulter, Peter S Sever, Björn Dahlöf, Hans Wedel, Gareth Beevers, Mark Caulfield, Rory Collins, Sverre E Kjeldsen, Arni Kristinsson, Gordon T McInnes, Jesper Mehlsen, Markku Nieminen, Eoin O'Brien, ASCOT investigators, The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. Journal of Hypertension. ,vol. 26, pp. 2103- 2111 ,(2008) , 10.1097/HJH.0B013E328310E0D9